CLEVELAND, May 25 /PRNewswire/ -- Demand for nanotechnology health care products
in the US is projected to increase nearly 50 percent per year to $6.5 billion
in 2009. Gains will be led by the introduction of new, improved cancer and central
nervous system therapies based on solubilization technologies. Diagnostic tests
based on nanoarrays and quantum dots, and imaging agents based on superparamagnetic
iron oxide nanoparticles will also see strong growth. In spite of progress in
introducing new products, the vast potential of nanotechnology in the health
care field will not be fully realized for at least a decade as stringent regulatory
barriers and technical complexities delay the commercialization of targeted
drug delivery systems, tissue regenerators and other breakthrough products.
However, by 2020, demand for nanotechnology health care products is projected
to exceed $100 billion. These and other trends are presented in Nanotechnology
in Health Care, a new study from The Freedonia Group, Inc., a Cleveland-based
market research firm
The need for new or improved medicines in several
therapeutic areas will lead to the increasing use
of nanotechnology in pharmaceutical applications.
Protein- and peptide-based compounds for cancer,
diabetes, infectious diseases and organ transplant
acceptance will account for most growth. Over the
long term, pharmaceutical applications for nanotechnology
will extend into most therapeutic classes and encompass
all types of formulations and delivery systems.
Advances in nanotechnology are also creating a wealth
of opportunities for the development of new, improved
medical diagnostic products and techniques. Nanoparticle
formulations of superparamagnetic iron oxide, gadolinium,
perfluorocarbon and specialty polymers will broaden
in vivo imaging capabilities by enabling the detection
of tumors, plaque, genetic defects and other disease
states at much earlier stages and with lower, safer
concentrations of contrast agents. Several medical
supplies and devices will emerge as key applications
for nanotechnology.
Nanomaterials are already gaining significant demand
as active ingredients of burn and wound dressings.
In the long term, advances in nanotechnology are
expected to lead to the introduction of new, improved
medical supply and device coatings as well as a new,
diverse group of medical implants. The greatest short-term
impact of nanotechnology in health care will be in
therapies and diagnostics for cancer and central
nervous system disorders.
Contact: Corinne Gangloff, pr@freedoniagroup.com ,
440-684-9600
Source: The Freedonia Group, Inc.
|
